ACC 2025 - 5 Highlights (Day 1 and Day 2) - International Episode

Notas do episódio

Send us a text Hey, Clube da Cardio community! This is a special episode — our very first international edition. In this episode, you will find the top 5 featured studies from the first two days of the American College of Cardiology Congress (ACC 2025): 1. Evolut Low Risk — 5-year follow-up 2. PRAGUE-25 — Lifestyle plus antiarrhythmic drugs versus ablation in obese patients with atrial fibrillation 3. FAME-3 — Fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting in multivessel coronary artery disease 4. SOUL — Semaglutide effects on cardiovascular outcomes in patients with type 2 diabetes 5. SMART-CHOICE — Clopidogrel versus aspirin as monotherapy after percutaneous coronary intervention Article analysis by Dr. Pâmela Valelongo — Cardiologist at Hospital Israelita Albert Einstein and Co-founder of Clube da Cardio. Voice by Andrea — Artificial Intelligent Assistant of Clube da Cardio. Enjoy the episode and share it with your colleagues! Follow us on Instagram: @clubedacardio Don’t forget to subscribe and share this episode with colleagues who may find it helpful. See you in the next one.